Paper · 42820108
Metalloimmunotherapies: metal-driven regulatory networks in the immune microenvironment.
Wen B and 5 others. Front Immunol, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Metalloimmunotherapies: metal-driven regulatory networks in the immune microenvironment. Papers, record 42820108. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42820108
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metalloimmunotherapies: metal-driven regulatory networks in the immune microenvironment.
- Journal
- Front Immunol
- Year
- 2026
- Publication types
- Journal Article, Review, Research Support, Non-U.S. Gov't
- Revised in PubMed
- 2026-10-27
Source PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metals | Major topic |
| Cellular Microenvironment | Major topic |
| Inflammation | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Signal Transduction | |
| Animals |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References183
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25,956,384 | A Review of Clinical Translation of Inorganic Nanoparticles. | AAPS J | 2015 | https://conductscience.org/library/papers/25956384 | PubMed |
| 2 | 32,684,520 | Immunotoxicity of nickel: Pathological and toxicological effects. | Ecotoxicol Environ Saf | 2020 | https://conductscience.org/library/papers/32684520 | PubMed |
| 3 | 35,362,540 | Research progress of anti-glioma chemotherapeutic drugs (Review). | Oncol Rep | 2022 | https://conductscience.org/library/papers/35362540 | PubMed |
| 4 | 39,187,583 | Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade. | Nat Nanotechnol | 2024 | https://conductscience.org/library/papers/39187583 | PubMed |
| 5 | 36,249,794 | Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36249794 | PubMed |
| 6 | 12,433,676 | Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. | Blood | 2003 | https://conductscience.org/library/papers/12433676 | PubMed |
| 7 | 28,629,136 | Zinc in Infection and Inflammation. | Nutrients | 2017 | https://conductscience.org/library/papers/28629136 | PubMed |
| 8 | 5,389,100 | Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). | J Biol Chem | 1969 | https://conductscience.org/library/papers/5389100 | PubMed |
| 9 | 40,642,900 | Zinc Alleviates Gut Barrier Dysfunction by Promoting the Methylation of AKT. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40642900 | PubMed |
| 10 | 27,160,489 | Extracellular magnesium and calcium blockers modulate macrophage activity. | Magnes Res | 2016 | https://conductscience.org/library/papers/27160489 | PubMed |
1 to 10 of 183
See all 183 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| NFKB1 | 4,790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42820108
GET https://conductscience.org/api/papers/v1/42820108/references?page=2